Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharma Omnium International was a French pharmaceutical company focused on the development, manufacturing, and commercialization of specialty medicines, particularly in the fields of gastroenterology and pain management. The company operated as a mid-sized pharmaceutical group with a strong presence in the European market through its own sales force and distribution networks. In 2004, Pharma Omnium was acquired by the Japanese pharmaceutical giant Eisai to strengthen Eisai's commercial infrastructure and product portfolio in Europe, specifically in France. Following the acquisition, its operations and products were integrated into Eisai's European division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharma Omnium.